BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 27
• 28

• FDA

  FDA Approves Aegerion Pharmaceuticals, Inc.'s Juxtapid

  December 27, 2012

   · 

  2 min read
• BioCapital

  GE Healthcare Recalls Resuscitator Components

  December 27, 2012

   · 

  2 min read
• Deals

  Major China Biopharma Buys Bayer AG’s Bay-Area Office/Lab Campus

  December 27, 2012

   · 

  1 min read
• Drug Development

  Isotechnika Pharma Inc. Announces That Lux Biosciences’ Phase 3 Uveitis Study Did Not Meet Primary Endpoint

  December 27, 2012

   · 

  1 min read
• Drug Development

  Celator Pharmaceuticals, Inc. Enrolls First Patient in Its Phase 3 Study of CPX-351 in Untreated High-Risk Acute Myeloid Leukemia

  December 27, 2012

   · 

  1 min read
• Deals

  Covidien plc Agrees to Buy Vascular Device Maker for Undisclosed Amount

  December 27, 2012

   · 

  1 min read
• BioCapital

  Medtronic, Inc. Recall Gets Class I Status From FDA

  December 27, 2012

   · 

  1 min read
• Deals

  PAREXEL International Acquires Liquent for $72 Million, Raises Earnings Expectations

  December 27, 2012

   · 

  8 min read
• FDA

  Alexza Pharmaceuticals, Inc.'s Agitation Drug Gets FDA Approval

  December 27, 2012

   · 

  10 min read
• Business

  Takeda Pharmaceuticals, Amylin Pharmaceuticals, Inc. Terminate $1 Billion Anti-Obesity Pact

  December 27, 2012

   · 

  3 min read